bioMerieux

Activities: Regulatory Analysis

Trending Articles

  1. Manufacturing Chemist Stand Side with Olon Spa We discover what exhibitors at CPHI Milan 2024 are showcasing LIVE!
  2. Novel innovation enhances productivity and output for Polish pharma company A consultative approach to service, delivery and problem solving ensured that a Polish pharmaceutical company received the equipment and technology it needed to ramp up...
  3. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  4. PTC Therapeutics' gene therapy Kebilidi bags FDA approval for AADC deficiency The gene therapy is the first to be approved in the US for direct administration to the brain, and tackles aromatic L-amino acid decarboxylase deficiency (AADC)
  5. Adragos Pharma enhances its sterile injectable production capabilities with new €13m ampoule filling line The novel line at the CDMO's Livron-sur-Drôme site in France will allow the company to manufacture more than 160 million ampoules for sterile injectables annually

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Regulatory

bioMérieux and JMI Laboratories partner to fight antimicrobial resistance

JMI Laboratories is a recent member of the Element Group, a leading global Testing, Inspection and Certification (TIC) company, through acquisition in November 2021
Drug Delivery

InDevR raises $9m in series B financing

ioMérieux will also become the exclusive distributor of the VaxArray portfolio in Europe
Regulatory

bioMérieux receives FDA clearance for mass spectrometry ID system

With 1.3 million deaths worldwide annually, antimicrobial resistance (AMR) is a global health priority
Manufacturing

Recombinant Factor C assay to aid demand for LAL endotoxin testing

Kevin Williams from bioMerieux discusses the recombinant Factor C assay that has been developed to help alleviate the pressures of a growing demand for the Limulus amoebocyte lysate assay
Analysis

bioMérieux launches automated diagnostic solution for microbial detection

EviSight Compact provides reliable results for increased product safety and reduces costs for pharmaceutical companies
Finance

BioMérieux acquires Hyglos for a total consideration of €24m

Expands its offering for the detection of endotoxins in pharmaceutical products
Analysis

Revolutionised and Robust: Environmental Identification Webinar - mid-October

Environmental identification, including moulds, by MALDI-TOF Mass Spectrometry
Subscribe now